Detrimental Side Effects of Repeated Ketamine Infusions in the Brain

Affiliations

Comment

Kenji Hashimoto. Am J Psychiatry. 2016.

. 2016 Oct 1;173(10):1044-1045.

doi: 10.1176/appi.ajp.2016.16040411.

¹ From the Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.

No abstract available

Keywords: Antidepressants; Drug Side Effects-Other; Mood Disorders-Unipolar; Other Aspects Of Psychopharmacology; Psychosis.

Comment in

Antidepressant Efficacy and Dosing Comparisons of Ketamine Enantiomers: Response to Hashimoto.
Singh JB; authors. Singh JB, et al. Am J Psychiatry. 2016 Oct 1;173(10):1045-1046. doi: 10.1176/appi.ajp.2016.16040411r. Am J Psychiatry. 2016. PMID: 27690560 No abstract available.

A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression.
Singh JB, Fedgchin M, Daly EJ, De Boer P, Cooper K, Lim P, Pinter C, Murrough JW, Sanacora G, Shelton RC, Kurian B, Winokur A, Fava M, Manji H, Drevets WC, Van Nueten L. Singh JB, et al. Am J Psychiatry. 2016 Aug 1;173(8):816-26. doi: 10.1176/appi.ajp.2016.16010037. Epub 2016 Apr 8. Am J Psychiatry. 2016. PMID: 27056608 Clinical Trial.